TGF-β and IL-21 cooperatively stimulate activated CD8(+) T cells to differentiate into Tc17 cells

Immunol Lett. 2016 Jun:174:23-7. doi: 10.1016/j.imlet.2016.04.006. Epub 2016 Apr 13.

Abstract

TGF-β together with IL-21 or IL-6 can drive the differentiation of naïve CD8(+) T cells into IL-17-producing CD8(+) T cells. These IL-17-producing CD8(+) T cells are termed Tc17 cells. Tc17 cells preserve plasticity under various conditions in vitro and in vivo. IFN-γ-producing CD8(+) T cells are termed Tc1 cells. However, Tc1 cells are considered relatively stable. In the present study, we show that the combination of TGF-β plus IL-21, but not IL-6, converts Tc1 cells into Tc17 cells; this conversion is associated with elevated RORα, RORγt, and Batf mRNA levels. These results indicate that Tc1 cells are skewed to the Tc17 cell phenotype under TGF-β plus IL-21-polarizing conditions. Furthermore, IL-6R is expressed on naïve, but not activated, CD8(+) T cells. In contrast, IL-21R is expressed on both naïve and activated CD8(+) T cells. Thus, differential expression profiles of IL-6R and IL-21R on naïve and activated CD8(+) T cells may be one mechanism by which TGF-β plus IL-21, but not IL-6, can drive activated CD8(+) T cells to differentiate into IL-17-producing cells. Taken together, these results provide a novel viewpoint for the plasticity of Tc1 cells.

Keywords: IL-21; IL-6; T cell plasticity; TGF-β; Tc1; Tc17.

MeSH terms

  • Animals
  • Biomarkers
  • CD8-Positive T-Lymphocytes / cytology*
  • CD8-Positive T-Lymphocytes / drug effects*
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Differentiation / drug effects*
  • Female
  • Gene Expression
  • Interferon-gamma / biosynthesis
  • Interleukins / pharmacology*
  • Lymphocyte Activation
  • Mice
  • Mice, Transgenic
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / genetics
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / metabolism
  • Receptors, Interleukin-21 / genetics
  • Receptors, Interleukin-21 / metabolism
  • T-Lymphocyte Subsets / cytology*
  • T-Lymphocyte Subsets / drug effects*
  • T-Lymphocyte Subsets / metabolism
  • Transforming Growth Factor beta / pharmacology*

Substances

  • Biomarkers
  • Interleukins
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • Receptors, Interleukin-21
  • Transforming Growth Factor beta
  • Interferon-gamma
  • interleukin-21